BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nag A, Paul S, Banerjee R, Kundu R. In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools. Comput Biol Med 2021;137:104818. [PMID: 34481181 DOI: 10.1016/j.compbiomed.2021.104818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Cui J, Chen J, Du S, Wang X, Zhang Y, Qian J, Chen H, Wei F, Cai Q, Jia J, Wu J. Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening. Virus Res 2022;321:198915. [PMID: 36084746 DOI: 10.1016/j.virusres.2022.198915] [Reference Citation Analysis]
2 Singh S, Banavath HN, Godara P, Naik B, Srivastava V, Prusty D. Identification of antiviral peptide inhibitors for receptor binding domain of SARS-CoV-2 omicron and its sub-variants: an in-silico approach. 3 Biotech 2022;12:198. [PMID: 35923684 DOI: 10.1007/s13205-022-03258-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 More-adate P, Lokhande KB, Swamy KV, Nagar S, Baheti A. GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro. Computers in Biology and Medicine 2022;147:105679. [DOI: 10.1016/j.compbiomed.2022.105679] [Reference Citation Analysis]
4 Nag A, Banerjee R, Paul S, Kundu R. Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study. Computers in Biology and Medicine 2022;146:105552. [DOI: 10.1016/j.compbiomed.2022.105552] [Reference Citation Analysis]
5 Alolga RN, Wang F, Zhang X, Li J, Tran LP, Yin X. Bioactive Compounds from the Zingiberaceae Family with Known Antioxidant Activities for Possible Therapeutic Uses. Antioxidants 2022;11:1281. [DOI: 10.3390/antiox11071281] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nag A, Dhull N, Gupta A. Evaluation of tea (Camellia sinensis L.) phytochemicals as multi-disease modulators, a multidimensional in silico strategy with the combinations of network pharmacology, pharmacophore analysis, statistics and molecular docking. Mol Divers 2022. [PMID: 35536529 DOI: 10.1007/s11030-022-10437-1] [Reference Citation Analysis]
7 Tuli H, Bansal P, Sharma V, Mohapatra RK, Dhama K, Priti, Sharma AK. Targeting Omicron (B.1.1.529) SARS CoV-2 spike protein with selected phytochemicals: an in-silico approach for identification of potential drug. J Exp Bio & Ag Sci 2022;10:396-404. [DOI: 10.18006/2022.10(2).396.404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fu Y, Ho W, Kang N, Tsai M, Wu J, Huang L, Weng C. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [DOI: 10.3389/fphar.2022.863082] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Elshemey WM, Elfiky AA, Ibrahim IM, Elgohary AM. Interference of Chaga mushroom terpenoids with the attachment of SARS-CoV-2; in silico perspective. Comput Biol Med 2022;145:105478. [PMID: 35421790 DOI: 10.1016/j.compbiomed.2022.105478] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Khattab AR, Teleb M, Kamel MS. In silico study of potential anti-SARS cell entry phytoligands from Phlomis aurea: a promising avenue for prophylaxis. Future Virol 2021;0. [PMID: 34745316 DOI: 10.2217/fvl-2021-0031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]